Cargando…
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma
SIMPLE SUMMARY: Osteosarcoma (OS) is the most common bone tumor in the pediatric population, and long-term survival occurs in less than a third of the population with metastatic or recurrent tumors. Secreted frizzled-related protein 2 (SFRP2) promotes metastatic OS cell migration and tumor angiogene...
Autores principales: | Nasarre, Patrick, Garcia, Denise I., Siegel, Julie B., Bonilla, Ingrid V., Mukherjee, Rupak, Hilliard, Eleanor, Chakraborty, Paramita, Nasarre, Cécile, Yustein, Jason T., Lang, Margaret, Jaffa, Aneese A., Mehrotra, Shikhar, Klauber-DeMore, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199140/ https://www.ncbi.nlm.nih.gov/pubmed/34070758 http://dx.doi.org/10.3390/cancers13112696 |
Ejemplares similares
-
MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma
por: Wofford, Wyatt O, et al.
Publicado: (2020) -
Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma
por: Tsuruta, James K., et al.
Publicado: (2017) -
Ultrasound Molecular Imaging of Secreted Frizzled Related Protein-2 Expression in Murine Angiosarcoma
por: Tsuruta, James K., et al.
Publicado: (2014) -
Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential
por: Techavichit, Piti, et al.
Publicado: (2016) -
Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)